Skip to content
cccskills
FreePublished on GitHub

es-rtcgm-adip-vs-mdis-smbg-t1d

This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.1 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

RT-CGM+ADIPs vs MDIs+SMBG for Type 1 Diabetes

STEP 1 — Gather Information

Confirm T1D diagnosis, current MDI+SMBG regimen (≥3 checks/day), age, hypoglycemia history, impaired awareness, patient tech readiness, and insurance/device access.

STEP 2 — Rule In / Rule Out

Is the patient with T1D using MDI with SMBG three or more times daily? If yes, proceed; if no, consider alternative glucose monitoring/insulin strategies.

STEP 3 — Classify or Stratify

Stratify by hypoglycemia risk: high (prior severe episodes or impaired awareness) vs lower risk. High-risk patients benefit most; lower-risk patients still considered based on preference and access.

STEP 4 — Decide

For qualifying patients, prescribe RT-CGM+ADIP with structured education; retain SMBG for calibration/confirmation; schedule follow‑up to assess TIR, hypoglycemia, and device tolerance.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on CGM without confirmatory SMBG; avoid in patients unable to respond to alerts or manage device wear; do not overlook cost/coverage barriers; never skip diabetes education on device use and hypoglycemia prevention.

Concrete Clinical Example

A 12‑year‑old with T1D on MDI+SMBG 4×/day reports nocturnal hypoglycemia and impaired awareness. After confirming eligibility, RT‑CGM+ADIP is started with training; SMBG used twice daily for calibration. At 3‑month review, TIR improves from 55% to 70% and severe hypoglycemia events drop from 2/month to 0.

Source: Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill